Indian Pharmacopoeia Commission will track weight loss drug side effects

India Apr 04, 2026

With weight-loss medications getting more popular, especially as generic semaglutide versions are expected to become widely available soon, the Indian government is stepping in to make sure they are safe.
The Indian Pharmacopoeia Commission (IPC) will now track and report any side effects, aiming to keep users better protected as these drugs become more widely available.

Crackdown on misleading GLP-1 ads

Officials are also cracking down on misleading advertisements for these prescription drugs, especially GLP-1 receptor agonists.
After recent warnings about promotion that may be in violation of the law, drug controllers across the country are teaming up to make sure companies follow the rules and stop shady marketing tactics.